Our division cares for infants, children and adolescents affected by diabetes or hormonal disorders regarding the thyroid, growth, sexual development, or puberty.
Our division is actively involved in the education of both residents and medical students. Our fellows play an integral role in educating these rotating trainees.
Pediatric residents and medical students spend four week electives in our various clinical settings. You will learn the fundamentals of the evaluation of patients with diabetes, short stature, tall stature, early or delayed puberty, disorders of sexual differentiation, thyroid disorders, pituitary disorders, and abnormal weight gain.
If you choose this elective during Diabetes Camp, then you will have the opportunity to spend either a day or a full week at the camp, which is sponsored by the American Diabetes Association. Residents and medical students will be assisting campers with diabetes management. As such, they will learn about blood sugar testing, insulin injections, insulin pump adjustments, insulin dose calculations and carbohydrate counting. This is a unique opportunity to learn how children with diabetes deal with everyday challenges including the effects of exercise or rainy days on blood sugars. As there will be more people with diabetes than without at camp, residents and medical students will learn more about diabetes than they can get from attending diabetes clinic.
We are involved in basic and clinical research focusing on insulin resistance/signaling and the treatment and prevention of overweight in the clinical setting. We also have several ongoing clinical studies involving patients with Type 1 and Type 2 diabetes. Our Diabetes Center is one of 83 sites across the United States participating in the Type 1 Diabetes Exchange, which is a unique platform for collaborative data collection and sharing. We have also been a participant of TrialNet, a federally-funded study for the screening and prevention of Type 1 diabetes. In addition to diabetes, we have participated in numerous trials investigating new drugs to promote growth or halt early puberty.
Opportunities are available for patients interested in participating in research studies led by our physicians with the assistance of experienced research personnel. To learn more about these trials, please click here.
Our division is part of UBMD Pediatrics, a member of UBMD Physicians' Group, the medical practice plan for the University at Buffalo. Our pediatric endocrinologists see patients at all three pediatric outpatient centers located in Amherst, Buffalo and Hamburg. Diabetes is available at our Buffalo pediatric outpatient center. We also provide consultations to inpatients at Oishei Children's Hospital.
Our Diabetes Center provides services for the clinical evaluation and management of both pediatric and adolescent patients with Type 1 and Type 2 diabetes. We have a team of nine board certified pediatric endocrinologists-diabetologists, a pediatric nurse practitioner, three nurses, a registered dietitian, and a part-time social worker. Together, we take care of more than 900 patients with diabetes in the Western New York community.
We have been recognized by the American Diabetes Association for the Education Recognition Program (ERP). Oishei is the only pediatric hospital to have received the designation of Diabetes Center of Excellence for Type 2 diabetes from the New York State Department of Health with a grant awarded between 2006-2011, which was replaced by a grant awarded in 2011 for Obesity Prevention.
In addition to the focus on the prevention and treatment of diabetes, we provide comprehensive care to those affected by endocrine disorders, such as:
We are also a New York State regional referral center for congenital hypothyroidism, congenital adrenal hyperplasia, and x-linked adrenoleukodystrophy newborn screening.
We are involved in many trials that bring the latest methods in management of diabetes and endocrine disorders to patients in Western New York. These include clinical trials investigating the use of novel medications in children, such as long acting growth hormone (Varsartis), along with various trials in youth with T1DM, such as T1D Exchange, as well as federally funded trials on screening and prevention of Type 1 diabetes via TrialNet.